14.05.2025

Teaser image to Industry Pitch Talks Recap

Industry Pitch Talks Recap

Visit to Daiichi Sankyo

We visited Daiichi Sankyo at their Munich Office and learned a lot about their great work in Pharma and AI/ML.

After a warm welcome by Felix Just and Roger Garriga, we presented work from

  • Simon Schallmoser on “Individualized Treatment Effects versus Ticagrelor in Acute Coronary Syndrome”
  • Shanshan Bai on “Generating Synthetic Oracle Datasets to Analyze Noise Impact: A Study on Building Function Classification Using Tweets”
  • Fiona Ewald on “A Guide to Feature Importance Methods for Scientific Inference”

Thanks again Felix and Roger, we are very much looking forward to more collaborations between #MCML and Daiichi Sankyo.

#event #research

Related

Tiny logo
Link to MCML at KDD 2026

07.08.2026

MCML at KDD 2026

MCML researchers are represented with 5 papers at KDD 2026.

Read more
Link to Benedikt Wiestler: We Want to Build a Time Machine

31.07.2026

Benedikt Wiestler: We Want to Build a Time Machine

MCML PI Benedikt Wiestler explains how AI models help to develop specific strategies in clinical therapy for brain tumor patients.

Read more
Link to Gaps in the Benchmark: Why Medical AI Fails in the Real World

28.07.2026

Gaps in the Benchmark: Why Medical AI Fails in the Real World

MCML researchers show in Nature Health how dynamic red teaming exposes hidden weaknesses in Medical AI beyond static benchmarks.

Read more
Link to Barbara Plank Becomes President of the Association for Computational Linguistics

26.07.2026

Barbara Plank Becomes President of the Association for Computational Linguistics

MCML PI Barbara Plank becomes President of the Association for Computational Linguistics, the world's leading NLP organization.

Read more
Link to Konstantin Riedl Receives 2026 SIAM Student Paper Prize

25.07.2026

Konstantin Riedl Receives 2026 SIAM Student Paper Prize

Former MCML Junior Member Konstantin Riedl receives the 2026 SIAM Student Paper Prize for research on nonconvex optimization.

Read more
Back to Top